Membership surges as Star ratings win an appeal
- Clover grew its Medicare Advantage membership to 157,000 members during Q2 2026.
- A court ruling forced CMS to recalculate Star ratings, placing all members in 4.5 Star plans for payment year 2027.
- CMS intends to appeal the court decision, which keeps regulatory risk in play.
- Counterpart Health could turn Clover Assistant into a higher-margin software business, but outside adoption remains unproven.
- Management stopped reporting Normalized BER, so medical cost trends are harder to read.
Fast growth meets a Star rescue
The bull case centers on massive membership momentum. Clover grew its Medicare Advantage base to 157,000 members during the second quarter of 2026. This scaling provides a larger revenue base to spread fixed costs across.
The company also won a major victory on quality scores. A District Court ruling forced CMS to recalculate Clover's Star ratings. As a result, all Medicare Advantage members are now enrolled in 4.5 Star plans for payment year 2027. This reverses a previous downgrade and restores the quality bonus.
The bear case remains tied to regulatory and cost uncertainty. CMS intends to appeal the court decision, meaning the 4.5 Star rating could face legal challenges. Meanwhile, management stopped providing the Normalized BER metric, giving investors less visibility into underlying medical costs as new members join.
The software story is the swing factor. Counterpart Health lets Clover sell its Clover Assistant technology to outside Medicare Advantage payors and providers. If that works, Clover could add a higher-margin business. If it fails, the company stays entirely dependent on its insurance margins.
Premiums first, software second
Clover makes most of its money by running Medicare Advantage plans. Members enroll in PPO or HMO plans, and Clover earns premium revenue while paying for member care. The key spread is simple: collect enough premium to cover medical claims, plan costs, and overhead.
The company says Clover Assistant helps doctors find and manage chronic disease earlier. The promise is better care and lower avoidable costs. That promise matters because medical claims can move quickly when a plan adds many new members.
Clover fully exited ACO REACH starting with the 2024 performance year. That made the company simpler, with one reportable segment: Insurance. It also removed a business that had been a drag on earnings.
Counterpart Health is Clover's newer bet. It packages Clover Assistant as software and tech-enabled services for external clinicians, payors, and providers. The model could carry better margins than insurance, but Clover must prove that rivals will buy technology from a company that also runs health plans.
What Clover sells
PPO Medicare Advantage plans
This is Clover's flagship insurance product and covers the large majority of members. A recent court ruling restored its rating to 4.5 Stars for payment year 2027.
HMO Medicare Advantage plans
The HMO plans are smaller than the PPO plans. They also sit at a 4.5 Star rating for payment year 2027 following the court decision.
Clover Assistant
Clover Assistant is the company's cloud-based software for doctors. It gives data-driven prompts meant to help detect and manage chronic diseases earlier.
Counterpart Health
Counterpart Health is the outside-facing software and services business built around Clover Assistant. It could become a higher-margin growth path if external Medicare Advantage payors adopt it.
One segment, PPO-heavy mix
As of Q2 2026, Clover reported one operating segment: Insurance. The product mix is highly concentrated, with the company serving 157,000 members largely in flagship PPO plans.
What could break the thesis
CMS Star rating appeal
High impact · Medium oddsClover won a court order forcing CMS to recalculate its Star ratings, placing members in 4.5 Star plans for payment year 2027. However, CMS intends to appeal this decision. If CMS wins the appeal, Clover could lose the crucial quality bonus.
Medical costs after rapid growth
High impact · Medium oddsClover added many members quickly. New members can bring care needs that are hard to price at first. Management also stopped reporting Normalized BER in early 2026, which lowers visibility into underlying medical cost trends.
Counterpart Health adoption risk
Medium impact · Medium oddsThe software idea is attractive because it could carry better margins than insurance. But Clover must sell Counterpart Health to outside payors and providers, including groups that may see Clover as a competitor. Slow adoption would leave less offset against future Medicare Advantage margin pressure.
Medicare Advantage rule changes
High impact · Medium oddsClover depends on Medicare Advantage rules, CMS payments, risk adjustment, quality ratings, and drug benefit rules. Future rule shifts can change revenue or costs faster than Clover can adjust pricing.
In one breath
What does Clover Health do?
Clover Health runs Medicare Advantage health plans, mainly PPO plans. It also sells technology through Counterpart Health, which is built around its Clover Assistant software.
Why do Star ratings matter for Clover Health?
Star ratings are CMS quality scores for Medicare plans. Higher ratings bring bonus payments, which improve profit margins. A court recently forced CMS to upgrade Clover's ratings to 4.5 Stars for payment year 2027, but CMS is appealing.
Is Counterpart Health already proven?
Not yet. It is a promising software path, but Clover still has to prove that outside Medicare Advantage payors and providers will buy and keep using it.
